Plasma PCSK9 levels and sepsis severity: an early assessment in the emergency department

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Clinical and Experimental Medicine (Testo stampato)

• Publication date

  2020-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10238-020-00658-9PMID 32869163
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-8 gene locus is associated with risk, severity and 28-day mortality of sepsis in a Chinese population

  2019cited by this paper
• Prognostic value of serial lactate levels in septic patients with and without shock

  2019cited by this paper
• Reduced plasma PCSK9 response in patients with bacteraemia is associated with mortality

  2019cited by this paper
• PCSK9 loss-of-function variants and risk of infection and sepsis in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort

  2019cited by this paper
• Effectiveness of integrative medicine group visits in chronic pain and depressive symptoms: A randomized controlled trial

  2019cited by this paper
• Prognostic value of sepsis-induced coagulation abnormalities: an early assessment in the emergency department

  2018cited by this paper
• Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors

  2018cited by this paper
• The Understanding and Management of Organism Toxicity in Septic Shock

  2018cited by this paper
• Inhibition of PCSK9 does not improve lipopolysaccharide-induced mortality in mice[S]

  2017cited by this paper
• PCSK9 at the crossroad of cholesterol metabolism and immune function during infections

  2017cited by this paper
• PCSK9 inhibitors in sepsis: a new potential indication?

  2017cited by this paper
• Role of lipoproteins and proprotein convertase subtilisin/kexin type 9 in endotoxin clearance in sepsis

  2016cited by this paper
• Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis

  2016cited by this paper
• Increased inflammatory markers with altered antioxidant status persist after clinical recovery from severe sepsis: a correlation with low HDL cholesterol and albumin

  2016cited by this paper
• Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis

  2016cited by this paper
• Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor

  2016cited by this paper
• Prognostic scores for early stratification of septic patients admitted to an emergency department-high dependency unit

  2014cited by this paper
• Serum lipid profile, cytokine production, and clinical outcome in patients with severe sepsis.

  2014cited by this paper
• PCSK9 is a critical regulator of the innate immune response and septic shock outcome

  2014cited by this paper
• Therapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles

  2014cited by this paper
• Inhibitory effects of simvastatin on staphylococcus aureus lipoteichoic acid-induced inflammation in human alveolar macrophages

  2014cited by this paper
• Why have clinical trials in sepsis failed?

  2014cited by this paper
• Bridging Lipid Metabolism and Innate Host Defense

  2014cited by this paper
• Proprotein convertase subtilisin/kexin type 9 potentially influences cholesterol uptake in macrophages and reverse cholesterol transport

  2013cited by this paper
• Increased Cholesterol Content in Gammadelta (γδ) T Lymphocytes Differentially Regulates Their Activation

  2013cited by this paper
• Inflammation stimulates the expression of PCSK9.

  2008cited by this paper
• Lipoproteins in inflammation and sepsis. II. Clinical aspects

  2006cited by this paper
• NEUTRALIZATION OF TUMOR NECROSIS FACTOR IN PRECLINICAL MODELS OF SEPSIS

  2005cited by this paper
• 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

  2003cited by this paper
• 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

  2003cited by this paper
• Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

  1998cited by this paper

• Protective impact of circulating ω-3 PUFAs on sepsis susceptibility through PCSK9 variant: evidence from Mendelian randomization and animal experiments

  2026cites this paper
• Association between step-down disposition based on the HACOR score and mortality in ED patients treated with non-invasive ventilation.

  2025cites this paper
• Sepsis-associated liver dysfunction confounds the association between circulating PCSK9 concentration and mortality in septic patients: A single-center retrospective cohort study.

  2025cites this paper
• Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

  2024cites this paper
• PCSK9 in T-cell function and the immune response

  2024cites this paper
• Vascular leak in sepsis: physiological basis and potential therapeutic advances

  2024cites this paper
• MiR-15b-5p and PCSK9 inhibition reduces lipopolysaccharide-induced endothelial dysfunction by targeting SIRT4

  2023cites this paper
• Circulating protein and lipid markers of early sepsis diagnosis and prognosis: a scoping review.

  2023cites this paper
• The association between PCSK9 inhibitor use and sepsis - A systematic review and meta-analysis of 20 double-blind, randomized, placebo-controlled trials.

  2023cites this paper
• Elevated circulating PCSK9 level is associated with 28-day mortality in patients with sepsis: a prospective cohort study

  2023cites this paper
• PCSK9 Inhibition: From Current Advances to Evolving Future

  2022cites this paper
• PCSK9 Promotes Endothelial Dysfunction During Sepsis Via the TLR4/MyD88/NF-κB and NLRP3 Pathways

  2022cites this paper
• PCSK9 Promotes Endothelial Dysfunction in Sepsis via TLR4/MyD88/NF-κB and NLRP3 Pathways

  2022cites this paper
• Biological variation of proprotein convertase subtilisin/kexin type 9 (PCSK9) in human serum.

  2021cites this paper
• The Multifaceted Biology of PCSK9

  2021cites this paper
• PCSK9 and inflammation. Maybe a role in autoimmune diseases? Focus on rheumatoid arthritis and systemic lupus erythematosus.

  2021cites this paper